Sttr phase i: developing a novel drug delivery system to enable an oral peptide based drug for kidney stones
Ended Project Grant Awarded Last action
- Award ID
- 1914232
- Recipient
-
Oxalo Therapeutics UEI JD11RKB2KWJ3
- Awarding agency
-
Division of Industrial Innovation
National Science Foundation
- Obligated
- $224,995
Award facts
- Assistance listing
- 47.041 Engineering
- Completion date
- Originally
- Funding agency
- National Science Foundation
- Place of performance
- Chicago, IL 60612, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $224,995 |
Quick answers
Who received award 1914232?
1914232 was awarded to Oxalo Therapeutics by Division of Industrial Innovation (National Science Foundation) on July 1, 2019.
How much is award 1914232 worth?
$224,995 has been obligated on 1914232.
Which agency awarded 1914232?
Division of Industrial Innovation (National Science Foundation) awarded 1914232, with funding from National Science Foundation.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award